July 9, 2026 · Form 4 insider transaction
Savitz Ryan sold 5,566 shares of Dianthus Therapeutics, Inc. at $101.97 per share, a transaction worth $567.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.; The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.95 to $102.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.